Δ9-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex:: an in vivo microdialysis study

被引:173
作者
Pistis, M
Ferraro, L
Pira, L
Flore, G
Tanganelli, S
Gessa, GL
Devoto, P
机构
[1] Univ Cagliari, BB Brodie Dept Neurosci, I-09042 Monserrato, CA, Italy
[2] Univ Ferrara, Pharmacol Sect, Dept Clin & expt Med, I-44100 Ferrara, Italy
[3] Neurosci SCaRL, I-09125 Cagliari, Italy
关键词
prefrontal cortex; in vivo microdialysis; dopamine; gamma-aminobutyric acid; glutamate; cannabinoid;
D O I
10.1016/S0006-8993(02)03055-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoid modulation of prefrontal cortex and hippocampus neuronal functioning has been correlated to the disruptive action of marijuana on memory tasks. This study investigates the effects of Delta(9)-tetrahydrocannabinol (Delta(9)-THC) on dopamine, glutamate and GABA levels in vivo by brain microdialysis in the prefrontal cortex. Delta(9)-THC (1 mg/kg, i.v.) significantly increased extracellular dopamine and glutamate levels and decreased GABA levels. These effects were prevented by the cannabinoid antagonist SR141716A (1 mg/kg, i.v.), which per se was ineffective. These results suggest that Delta(9)-THC disrupt the normal interplay between neuro transmitters in this area and may bear relevance in understanding neuronal mechanisms underlying cannabinoid-induced cognitive deficits. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 28 条
[1]   Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons [J].
Auclair, N ;
Otani, S ;
Soubrie, P ;
Crepel, F .
JOURNAL OF NEUROPHYSIOLOGY, 2000, 83 (06) :3287-3293
[2]  
Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO
[3]  
2-R
[4]  
Carr DB, 1998, SYNAPSE, V29, P193
[5]  
CHEN JP, 1990, EUR J PHARMACOL, V190, P259
[6]   Studies on [3H]CP-55940 binding in the human central nervous system:: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use [J].
Dean, B ;
Sundram, S ;
Bradbury, R ;
Scarr, E ;
Copolov, D .
NEUROSCIENCE, 2001, 103 (01) :9-15
[7]   Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids [J].
Diana, M ;
Melis, M ;
Gessa, GL .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (09) :2825-2830
[8]   The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex:: an in vivo and in vitro study [J].
Ferraro, L ;
Tomasini, MC ;
Gessa, GL ;
Bebe, BW ;
Tanganelli, S ;
Antonelli, T .
CEREBRAL CORTEX, 2001, 11 (08) :728-733
[9]   Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate γ-aminobutyric acid levels [J].
Ferraro, L ;
Tomasini, MC ;
Cassano, T ;
Bebe, BW ;
Siniscalchi, A ;
O'Connor, WT ;
Magee, P ;
Tanganelli, S ;
Cuomo, V ;
Antonelli, T .
JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (02) :298-302
[10]   Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex [J].
Gessa, GL ;
Devoto, P ;
Diana, M ;
Flore, G ;
Melis, M ;
Pistis, M .
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (06) :642-649